sb 239063 has been researched along with Albuminuria in 1 studies
SB 239063: structure in first source
SB-239063 : A member of the class of imidazoles carrying 4-hydroxycyclohexyl, 4-fluorophenyl and 2-methoxypyrimidin-4-yl substituents at positions 1, 4 and 5 respectively.
Albuminuria: The presence of albumin in the urine, an indicator of KIDNEY DISEASES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lenhard, SC | 1 |
| Nerurkar, SS | 1 |
| Schaeffer, TR | 1 |
| Mirabile, RC | 1 |
| Boyce, RW | 1 |
| Adams, DF | 1 |
| Jucker, BM | 1 |
| Willette, RN | 1 |
1 other study available for sb 239063 and Albuminuria
| Article | Year |
|---|---|
p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 2. Improved renal function as assessed by dynamic contrast-enhanced magnetic resonance imaging.
Topics: Albuminuria; Animals; Contrast Media; Creatinine; Dietary Fats; Endothelium, Vascular; Enzyme Inhibi | 2003 |